Last week, AMCP convened a diverse group of stakeholders for its Precision Medicine Partnership Forum to examine solutions that improve access, consistency, and quality in precision oncology.
AMCP Receives 2025 Power of Associations Silver Award for Addressing Health Disparities in Medication Use and Access Awareness Campaign
Alexandria, VA – Academy of Managed Care Pharmacy (AMCP) has been recognized as a Power of Associations Silver Award by the American Society of Association Executives (ASAE) for its successful Health Disparities in Medication Use and Access Awareness initiative.
AMCP is actively addressing disparities in medication use and access through a multifaceted approach that integrates data-driven decision-making, education, and policy advocacy. AMCP emphasizes the importance of collecting and analyzing data on race, ethnicity, and socioeconomic status to inform equitable formulary design, benefit offerings, and clinical interventions. Managed care pharmacy professionals play a pivotal role by conducting cost-effectiveness and health outcomes research, managing chronic diseases, and promoting preventive care such as immunizations and screenings. During the COVID-19 pandemic, these professionals leveraged population-wide data to identify care gaps and mobilize targeted resources, demonstrating the critical impact of managed care in advancing health equity. AMCP also supports the development of a health equity–focused workforce through training and education initiatives aimed at ensuring all patients have access to high-quality, culturally competent care
“Congratulations to AMCP for exemplifying the impact associations have on the industries and professions they represent, and on society at large,” said ASAE President and CEO Michelle Mason, FASAE, CAE. “It’s always so incredibly satisfying to see associations going above and beyond their everyday mission to change the world. We’re very proud to spotlight this award-winning initiative.”
“We used an omnichannel approach, including our national meetings, with over 3,000 attendees, AMCP Learn webinar platform, social media, email communications, a dedicated resource page on AMCP.org, AMCP Foundation Research Symposium on Health Disparities and articles in JMCP, AMCP’s peer-reviewed scientific journal.” Said AMCP VP of Marketing Erica Klinger.
“This campaign allowed us to develop new partnerships. Our partners have included patient advocacy organizations such as the Skin of Color Society and the Sickle Cell Disease Association of the Midwest, and Diversity, Equity, and Inclusion corporate teams.”
To learn more about AMCP’s efforts to combat disparities in medication use and access, visit our Disparity Resources.
MEDIA CONTACT: Jack Goldberg, 1-703-684-2633, @email
About AMCP
AMCP is the professional association leading the way to help patients get the medications they need at a cost they can afford. AMCP’s diverse membership of pharmacists, physicians, nurses, biopharmaceutical professionals, and other stakeholders leverage their specialized expertise in clinical evidence and economics to optimize medication benefit design and population health management and help patients access cost-effective and safe medications and other drug therapies. AMCP members improve the lives of nearly 300 million Americans served by private and public health plans, pharmacy benefit management firms, and emerging care models.
About The Power of Associations Awards
ASAE’s Power of Associations Awards recognize the association community’s economic and societal contributions locally, nationally and globally. ASAE will celebrate The Power of Associations Award recipients during its annual Summit Awards Dinner on September 25, 2025, at the National Building Museum in Washington, DC.
Related
Removal of all members of ACIP at the Centers for Disease Control & Prevention (CDC) is nothing short of alarming. Vaccines are a vital component of American public health infrastructure, and their safety and efficacy is well-established by reliable clinical evidence. Pharmacists, including AMCP members, provide patients with vaccines that prevent serious illness, hospitalizations, and even death. In many states, pharmacists’ ability to administer these life-saving vaccines are tied to ACIP recommendations.
PDTs are evidence-based treatments that use software or virtual tools, and sometimes hardware, to deliver a clinical benefit to patients. They have many known uses, helping Americans identify, treat, and manage illnesses across a wide range of conditions, including post-traumatic stress disorder (PTSD), diabetes management, substance and opioid use disorder, attention-deficit hyperactivity disorder (ADHD), chronic back pain, decreasing eyesight, and more. PDTs are subject to review and authorization by the Food & Drug Administration (FDA) and must be prescribed by a health care provider.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
